The tariff classification of IDD-D™ Propofol Injectable Emulsion 2%, imported put up in vials for use in Phase III clinical trials, from Sweden
Reasoning
The tariff classification of IDD-D™ Propofol Injectable Emulsion 2%, imported put up in vials for use in Phase III clinical trials, from Sweden
Cite this ruling
CBP Ruling J83036 (3004909130): The tariff classification of IDD-D™ Propofol Injectable Emulsion 2%, imported put up in vials for use in Phase III clinical trials, from Sweden
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Vascepa™ imported in dosage form, from the Netherlands
The tariff classification of Linaclotide (CAS-851199-59-2), imported in dosage form, from Sweden
The tariff classification of Telmisartan, Escitalopram Oxalate, and Pioglitazone Hydrochloride imported in dosage form, from India
The tariff classification of Telmisartan, Escitalopram Oxalate, and Pioglitazone Hydrochloride imported in dosage form, from India
The tariff classification of Telmisartan, Escitalopram Oxalate, and Pioglitazone Hydrochloride imported in dosage form, from India